1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. WNK Kinase
  4. WNK1 Isoform

WNK1

WNK1 is a serine/threonine kinase that regulates ion balance by activating SPAK/OSR1 signaling, which phosphorylates cation-chloride cotransporters including NKCC1, NKCC2, and NCC[1]. Mechanistically, WNK1 and WNK4 phosphorylate and activate SPAK/OSR1, placing WNK1 within a conserved WNK-SPAK/OSR1 transporter-control pathway[2]. In disease models, WNK1 or WNK4 mutations cause pseudohypoaldosteronism type II/familial hyperkalemic hypertension, linking pathway activation to renal salt handling, hyperkalemia, and hypertension[3]. Compared with WNK4, WNK1-driven familial hyperkalemic hypertension remains SPAK-dependent but shows different distal-nephron effects on NCC abundance and phosphorylation[4]. For experimental applications, WNK463 provides a pan-WNK inhibitor tool that affects cardiovascular, renal, blood-pressure, fluid, and electrolyte phenotypes in rodent hypertension models[5].

WNK1 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-100626
    WNK463
    Inhibitor 99.75%
    WNK463 is an orally bioavailable pan-With-No-Lysine (K) (WNK)-kinase inhibitor with IC50s of 5 nM, 1 nM, 6 nM, and 9 nM for WNK1, WNK2, WNK3, and WNK4, respectively.